August 19, 2019 ESC preview – Medicines Company hopes for a starring role Novartis has been reduced to a Paragon data dredge, but results with The Medicines Company’s inclisiran, Astrazeneca’s Brilinta and Cellaegis’ AutoRIC device should pique interest.
May 21, 2018 Boston Scientific’s plan to keep the rhythm going An acquisitive company has a plan for the future.
May 11, 2018 Ablation groups scramble to cope with Cabana The Cabana trial has finally reported, but the data are inconclusive.
